Deep Tide TechFlow News, August 7, Processa Pharmaceuticals (NASDAQ: PCSA) announced today that it has received a strategic investment and plans to incorporate cryptocurrency into its corporate financial management strategy. The company has engaged LifeSci Capital as an advisor to assist in implementing related strategies.

Processa stated that this decision aims to diversify its capital structure and enhance financial flexibility. The company will explore the use of blockchain assets to support its clinical development projects, while strictly adhering to regulatory standards.